Neurosciences in Germany Can
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
The Kraepelinian Tradition Paul Hoff, MD, Phd
Clinical research The Kraepelinian tradition Paul Hoff, MD, PhD Introduction n the 21st century, Emil Kraepelin’s views remain a majorI point of reference, especially regarding nosol- ogy and research strategies in psychiatry. However, the “neo-Kraepelinian” perspective has also been criticized substantially in recent years, the nosological dichotomy Emil Kraepelin (1856–1926) was an influential figure in of schizophrenic and affective psychoses being a focus the history of psychiatry as a clinical science. This pa- of this criticism. A thorough knowledge and balanced per, after briefly presenting his biography, discusses interpretation of Kraepelin’s work as it developed along- the conceptual foundations of his concept of mental side the nine editions of his textbook (published between illness and follows this line of thought through to late 1883 and 1927)1 is indispensable for a profound under- 20th-century “Neo-Kraepelinianism,” including recent standing of this important debate, and for its further de- criticism, particularly of the nosological dichotomy of velopment beyond the historical perspective. endogenous psychoses. Throughout his professional life, Kraepelin put emphasis on establishing psychiatry A brief biography as a clinical science with a strong empirical background. He preferred pragmatic attitudes and arguments, thus Emil Kraepelin was born in Neustrelitz (Mecklenburg, underestimating the philosophical presuppositions of West Pomerania, Germany) on February 15, 1856. He his work. As for nosology, his central hypothesis is the studied medicine in Leipzig and Wuerzburg from 1874 un- existence and scientific accessibility of “natural disease til 1878. He worked as a guest student at the psychiatric entities” (“natürliche Krankheitseinheiten”) in psychi- hospital in Wuerzburg under the directorship of Franz von atry. -
Women Neuropsychiatrists on Wagner-Jauregg's Staff in Vienna at the Time of the Nobel Award: Ordeal and Fortitude
History of Psychiatry Women neuropsychiatrists on Wagner-Jauregg’s staff in Vienna at the time of the Nobel award: ordeal and fortitude Lazaros C Triarhou University of Macedonia, Greece Running Title: Women Neuropsychiatrists in 1927 Vienna Corresponding author: Lazaros C. Triarhou, Laboratory of Theoretical and Applied Neuroscience and Graduate Program in Neuroscience and Education, University of Macedonia, Egnatia 156, Thessalonica 54006, Greece. E-Mail: [email protected] ORCID id: 0000-0001-6544-5738 2 Abstract This article profiles the scientific lives of six women on the staff of the Clinic of Neurology and Psychiatry at the University of Vienna in 1927, the year when its director, Julius Wagner-Jauregg (1857–1940), was awarded the Nobel Prize in Physiology or Medicine. They were all of Jewish descent and had to leave Austria in the 1930s to escape from the National Socialist regime. With a solid background in brain science and mental disorders, Alexandra Adler (1901–2001), Edith Klemperer (1898–1987), Annie Reich (1902–1971), Lydia Sicher (1890– 1962) and Edith Vincze (1900–1940) pursued academic careers in the United States, while Fanny Halpern (1899–1952) spent 18 years in Shanghai, where she laid the foundations of modern Chinese psychiatry, before going to Canada. At the dawn of their medical career, they were among the first women to practice neurology and psychiatry both in Austria and overseas. Keywords Women in psychiatry, Jewish physicians, University of Vienna, Interwar period, Austrian Annexation 3 Introduction There is a historic group photograph of the faculty and staff of the Neurology and Psychiatry Clinic in Vienna, taken on 7 November 1927 (Figure 1). -
History of Alzheimer's Disease
Print ISSN 1738-1495 / On-line ISSN 2384-0757 Dement Neurocogn Disord 2016;15(4):115-121 / https://doi.org/10.12779/dnd.2016.15.4.115 DND REVIEW History of Alzheimer’s Disease Hyun Duk Yang,1,2 Do Han Kim,1 Sang Bong Lee,3 Linn Derg Young,2,4,5 1Harvard Neurology Clinic, Yongin, Korea 2Brainwise Co. Ltd., Yongin, Korea 3Barun Lab Inc., Yongin, Korea 4Department of Business Administration, Cheongju University, Cheongju, Korea 5Boston Research Institute for Medical Policy, Yongin, Korea As modern society ages rapidly, the number of people with dementia is sharply increasing. Direct medical costs and indirect social costs for dementia patients are also increasing exponentially. However, the lack of social awareness about dementia results in difficulties to dementia patients and their families. So, understanding dementia is the first step to remove or reduce the stigma of dementia patients and promote the health of our community. Alzheimer’s disease is the most common form of dementia. The term, ‘Alzheimer’s disease’ has been used for over 100 years since first used in 1910. With the remarkable growth of science and medical technologies, the techniques for diagnosis and treat- ment of dementia have also improved. Although the effects of the current symptomatic therapy are still limited, dramatic improvement is ex- pected in the future through the continued research on disease modifying strategies at the earlier stage of disease. It is important to look at the past to understand the present and obtain an insight into the future. In this article, we review the etymology and history of dementia and pre- vious modes of recognizing dementia. -
The Tangled Story of Alois Alzheimer
Bratisl Lek Listy 2006; 107 (910): 343345 343 TOPICAL REVIEW The tangled story of Alois Alzheimer Zilka N, Novak M Institute of Neuroimmunology, AD Centre of Excellence, Slovak Academy of Sciences, Bratislava, Slovakia. [email protected] Abstract In 1907, Bavarian psychiatrist Alois Alzheimer, who is considered to be a founding father of neuropa- thology, was first to describe the main neuropathologic characteristics of the peculiar disease in the brain of a woman showing progressive dementia when she was in her early 50s. Using a newly deve- loped Bielschowskys silver staining method, Alzheimer observed degenerating neurons with bundles of fibrils (neurofibrillary tangles) and miliary foci of silver-staining deposits scattered over the cortex (senile plaques). In 1910 Emil Kraepelin (Alois Alzheimers superior) coined the term Alzheimers disease to distinguish the presenile form of dementia from the more common senile variant. Alzheimers findings were followed up, and soon a number of reports of similar cases appeared in the literature. During the time, both pathological hallmarks of Alzheimers disease became the gold standard for post-mortem diagnosis of the disease. One hundred years later, dementia of Alzheimers type is con- sidered to be one of the most devastating illnesses of old age. Despite intensive research the cause of the disease still remains elusive (Fig. 2, Ref. 17). Key words: Alzheimers disease, Alois Alzheimer, Augusta D, neurofibrillary tangles, senile plaques. Alois Alzheimer was born in June 14, 1864 in Markbreit am pathology of the nervous system, studying in particular the nor- Main in Southern Germany. He commenced the study of medi- mal and pathological anatomy of the cerebral cortex. -
From Early Pioneers to Recent Brain Network Findings
Biological Psychiatry: Review CNNI Connectomics in Schizophrenia: From Early Pioneers to Recent Brain Network Findings Guusje Collin, Elise Turk, and Martijn P. van den Heuvel ABSTRACT Schizophrenia has been conceptualized as a brain network disorder. The historical roots of connectomics in schizophrenia go back to the late 19th century, when influential scholars such as Theodor Meynert, Carl Wernicke, Emil Kraepelin, and Eugen Bleuler worked on a theoretical understanding of the multifaceted syndrome that is currently referred to as schizophrenia. Their work contributed to the understanding that symptoms such as psychosis and cognitive disorganization might stem from abnormal integration or dissociation due to disruptions in the brain’s association fibers. As methods to test this hypothesis were long lacking, the claims of these early pioneers remained unsupported by empirical evidence for almost a century. In this review, we revisit and pay tribute to the old masters and, discussing recent findings from the developing field of disease connectomics, we examine how their pioneering hypotheses hold up in light of current evidence. Keywords: Association fibers, Connectomics, Dissociation, History of psychiatry, Integration, Schizophrenia http://dx.doi.org/10.1016/j.bpsc.2016.01.002 The hypothesis that schizophrenia is a disorder of brain connectomics in schizophrenia, Figure 1 shows a selection of connectivity has its roots in the 19th century, in which mental visionary scholars that contributed to the development of the illness was first attributed to the brain [for review, see (1)]. disconnectivity theory of schizophrenia. However, the methodological tools to test the disconnectivity Of note, the nomenclature in psychiatry has changed theory were long lacking, leaving it unsupported by neuro- substantially over the years (7). -
Franz Nissl (1860-1919), Noted Neuropsychiatrist and Neuropathologist, Staining the Neuron, but Not Limiting It
Dement Neuropsychol 2019 September;13(3):352-355 History Note http://dx.doi.org/10.1590/1980-57642018dn13-030014 Franz Nissl (1860-1919), noted neuropsychiatrist and neuropathologist, staining the neuron, but not limiting it Marleide da Mota Gomes1 ABSTRACT. Franz Alexander Nissl carried out studies on mental and nervous disorders, as a clinician, but mainly as a pathologist, probably the most important of his time. He recognized changes in glial cells, blood elements, blood vessels and brain tissue in general, achieving this by using a special blue stain he himself developed – Nissl staining, while still a medical student. However, he did not accept the neuron theory supported by the new staining methods developed by Camillo Golgi and Santiago Ramón y Cajal. Nissl had worked with the crème de la crème of German neuropsychiatry, including Alois Alzheimer, besides Emil Kraepelin, Korbinian Brodmann and Walther Spielmeyer. He became (1904), Kraepelin’s successor as Professor of Psychiatry and Director of the Psychiatric Clinic, in Heidelberg. Moreover, in 1918, the year before Nissl´s death, Kraepelin offered him a research position as head of the Histopathology Department of the newly founded “Deutsche Forschungsanstalt fur Psychiatrie” of the Max Planck Institute for Psychiatry, in Munich. Key words: Franz Nissl, neuropathology, staining method, neuron theory. FRANZ NISSL (1860-1919), NOTÁVEL NEUROPSIQUIATRA E NEUROPATOLOGISTA, TINGINDO O NEURÔNIO, MAS NÃO O LIMITANDO RESUMO. Franz Alexander Nissl realizou estudos sobre transtornos mentais e nervosos, como clínico, mas principalmente como patologista, provavelmente o mais importante de seu tempo. Ele reconheceu mudanças nas células gliais, elementos sangüíneos, vasos sangüíneos e tecido cerebral em geral, realizando-o por meio de um corante azul especial desenvolvida por ele mesmo – coloração de Nissl, ainda como estudante de medicina. -
The Neuro Nobels
NEURO NOBELS Richard J. Barohn, MD Gertrude and Dewey Ziegler Professor of Neurology University Distinguished Professor Vice Chancellor for Research President Research Institute Research & Discovery Director, Frontiers: The University of Kansas Clinical and Translational Science Grand Rounds Institute February 14, 2018 1 Alfred Nobel 1833-1896 • Born Stockholm, Sweden • Father involved in machine tools and explosives • Family moved to St. Petersburg when Alfred was young • Father worked on armaments for Russians in the Crimean War… successful business/ naval mines (Also steam engines and eventually oil).. made and lost fortunes • Alfred and brothers educated by private teachers; never attended university or got a degree • Sent to Sweden, Germany, France and USA to study chemical engineering • In Paris met the inventor of nitroglycerin Ascanio Sobrero • 1863- Moved back to Stockholm and worked on nitro but too dangerous.. brother killed in an explosion • To make it safer to use he experimented with different additives and mixed nitro with kieselguhr, turning liquid into paste which could be shaped into rods that could be inserted into drilling holes • 1867- Patented this under name of DYNAMITE • Also invented the blasting cap detonator • These inventions and advances in drilling changed construction • 1875-Invented gelignite, more stable than dynamite and in 1887, ballistics, predecessor of cordite • Overall had over 350 patents 2 Alfred Nobel 1833-1896 The Merchant of Death • Traveled much of his business life, companies throughout Europe and America • Called " Europe's Richest Vagabond" • Solitary man / depressive / never married but had several love relationships • No children • This prompted him to rethink how he would be • Wrote poetry in English, was considered remembered scandalous/blasphemous. -
Brain Research and Clinical Psychiatry: Establishment of a Psychiatry Brain Bank in Japan
INVITED REVIEW ARTICLE Nagoya J. Med. Sci. 80. 309–315, 2018 doi:10.18999/nagjms.80.3.309 Brain research and clinical psychiatry: establishment of a psychiatry brain bank in Japan Shuji Iritani, Chikako Habuchi, Hirotaka Sekiguchi, and Youta Torii Department of Clinical Psychiatry, Nagoya University Graduate School of Medicine, Nagoya, Japan ABSTRACT The Japan Agency of Medical Research and Development (AMED) has approved the budget for the 5-year project called Establishment of the JAPAN Brain Bank Network, which commenced in 2016. This project was established with the aim of storing brain tissue samples to enable research on the etiologies and mechanisms of psychiatric diseases, which would eventually improve standards of clinical treatment for these diseases. Japanese researchers in the field of biological psychiatry have historically depended on Western brain banks, particularly from Europe and the United States, which is regrettable. To remedy this situation and improve the Japanese research standards, attempts for establishing an autonomous Japanese brain bank are ongoing. Reviews of the previous attempts on elucidating the etiopathology of neuropsychiatric diseases reveal that rapid advances result from studies on tissue samples from diseased brains. For example, in the Kraepelin era, i.e. in 1900 years before and after, long-term, resolute research on diseased brain specimens ultimately led to the discoveries of entities such as Alzheimer disease and Lewy body disease. The recent advances in techniques of neuroimaging and molecular biology have resulted in a shift of interest from brain tissue analysis. However, the integration of findings of all these techniques is recommended going forward, with a shift in focus back to brain tissue analysis. -
Biography of Alois Alzheimer
BIOGRAPHY OF ALOIS ALZHEIMER (1864-1915) AOUAD MayaAOUAD Maya Joint masterJoint in neuroscience master in neuroscience Alzheimer's disease is a neurodegenerative disorder. It is characterized clinically by a progressive decline of several cognitive functions and it is the most common cause of dementia. The prevalence of this disease is expected to increase during the next decades because of the increasing of the human age population. It is one of the greatest burdens in modern medicine. The symptoms of Alzheimer's disease were first described in the early 1900s by Emil Kraepelin, a German psychiatrist. The neuropathological features were later described by Alois Alzheimer, another German psychiatrist, who worked in Kraepelin's laboratory. The description of this disease is his most known contribution to Neuroscience. However, the research on this disease represents only a small part of Alzheimer's interests, which also included the histopathology of the cerebral cortex in the mentally ill. Who is Alois Alzheimer and what were the main stages of his carrier? Alois Alzheimer was born on the 14th of June 1864 in Markbreit a small Bavarian village, Southern Germany where his father was notary. Excelling in science at school he studied medicine in Berlin, Tubingen and Wurzburg where he wrote his doctoral theses on ceruminal glands and graduated with a medical degree in 1887. In December 1888 he began his medical career as a resident at the Hospital for the Mentally ill and Epileptics in Frankfurt am Main where he stayed for seven years and was subsequently promoted to senior physician. Later Alzheimer worked seven more years as an assistant physician at the Municipal Hospital for Lunatics and Epileptics also called Asylium in Frankfurt headed by Emil Sioli. -
Images-In-Psychiatry-Karl-Kleist.Pdf
Images in Psychiatry Karl Kleist, 1879–1960 K arl Kleist aspired to take up neuropsychiatry under the ing cerebral lesions, Kleist refined Wernicke’s typology of aphasias most prominent figures of his time. Theodor Ziehen exposed him and stratified his structural theory of consciousness. He assem- to Ernst Mach’s empiriocriticism, and Carl Wernicke exposed him bled psychopathological symptoms in semiologic complexes to Gustav Theodor Fechner’s psychophysics. Struck by Wernicke’s similar to Alfred Erich Hoche’s axis-syndromes. For these syn- premature death, Kleist was determined to advance descriptive dromes, opposite poles were recognized to facilitate empathic ac- psychopathology and neuropsychology. His meticulous observa- cess to a given patient. Furthermore, Kleist combined Wernicke’s tions of mental and psychomotor phenomena were framed by syndromatic and Emil Kraepelin’s prognostic principles to clas- Wernicke’s psychic reflex arc, Theodor Meynert’s cerebral connec- sify endogenous psychoses far beyond the genuine Kraepelinian tionism, and associationism. While directing neurological de- dichotomy. Avoiding hybridization hypotheses, Kleist accommo- partments at World War I military hospitals, Kleist confirmed dated bipolar manic-depressive illness, unipolar affective disor- similarities between organic mental disorders and endogenous ders, and marginal (atypical, particularly cycloid) psychoses to psychoses. Consequently, he identified the latter with less crude phasophrenias. Schizophrenias were restricted to rather guarded manifestations -
Who Was Emil Kraepelin and Why Do We Remember Him 160 Years Later?
TRAMES, 2016, 20(70/65), 4, 317–335 WHO WAS EMIL KRAEPELIN AND WHY DO WE REMEMBER HIM 160 YEARS LATER? Jüri Allik1 and Erki Tammiksaar1,2 1University of Tartu and 2Estonian University of Life Sciences Abstract. In order to commemorate Kraepelin’s 160th birthdate and the 130th year from his first professorship, a conference “Emil Kraepelin 160/130” was held in the same Aula of the University of Tartu where 130 years earlier Kraepelin expressed his views about the relationship between psychiatric illnesses and brain functions. This special issue is composed of talks that were held at the conference. However, papers presented in this special issue are in most cases much more elaborated versions of the presented talks. In this introductory article, we remember some basic facts about Emil Kraepelin’s life and the impact he made in various areas, not only in psychiatry. We also try to create a context into which papers presented in this special issue of Trames can be placed. Keywords: Emil Kraepelin; history of psychiatry and psychology; University of Dorpat/Tartu DOI: 10.3176/tr.2016.4.01 Usually, Emil Wilhelm Magnus Georg Kraepelin (1856–1926) is identified as the founder of modern scientific psychiatry (Decker 2004, Engstrom & Kendler 2015, Healy, Harris, Farquhar, Tschinkel, & Le Noury 2008, Hippius & Mueller 2008, Hoff 1994, Jablensky, Hugler, Voncranach, & Kalinov 1993, Steinberg 2015). However, it took some time to recognize Kraepelin’s other contributions to many other areas such as psychopharmacology (Müller, Fletcher, & Steinberg 2006, Saarma & Vahing 1976, Schmied, Steinberg, & Sykes 2006, Vahing & Mehilane 1990), sleep research (Becker, Steinberg, & Kluge 2016) and psychology (Eysenck & Frith 1977, Steinberg 2015). -
Gudden, Huguenin, Hitzig : Hirnpsychiatrie Im Burghölzli 1869
Gudden, Huguenin, Hitzig Hirnpsychiatrie imBurghölzli 1869-1879 Von Erwin H. Ackerknecht Das Burghölzli, die psychiatrische Klinik der Universität Zürich, begann sich gegen das Ende des 19. und zu Anfang des 20. Jahrhunderts eines internationalen Rufs zu erfreuen. Ihre Direktoren in diesen Jahrzehnten, Auguste Forel und Eugen Bleuler, sind unvergessen. Weniger freundlich ist die Geschichte mit den ersten drei Direktoren Gudden, Huguenin und Hitzig umgegangen, welche die Anstalt von 1870 bis 1879 leiteten. Eine Beschäftigung mit ihnen ist nicht nur gerecht, sondern auch dadurch gerechtfertigt, daß diese drei Männer außerordent- lieh typisch für die dominierende Tendenz der wissenschaftlichen Psychiatrie dieser Zeit sind, die sogenannte Hirnpsychiatrie, welche aus Mangel an histo- rischem Verständnis heute einfach über die Schulter angesehen wird. Die Mehrheit der deutschen Psychiater um 1850 waren noch immer söge- nannte «Irrenväter». Nur wenige Psychiater verfügten über Universitätskliniken. Die meisten lebten in großen und kleinen Anstalten inmitten ihrer Kranken. Die großen Erfolge der Anatomie, Physiologie und pathologischen Anatomie in der Medizin im allgemeinen führten nun die jungen Optimisten, die über diese Irren- väterrolle hinausgehen wollten, auf den Weg der Hirnanatomie, Hirnphysiologie und pathologischen Anatomie des Gehirns h Monakow, selbst ursprünglich Psychiater, weist mit Stolz darauf hin, daß die wesentlichen hirnanatomischen Entdeckungen dieser Zeit nicht von Physiologen und Anatomen, sondern von Psychiatern wie eben Gudden, Hitzig etc. gemacht worden sind*. Gudden (geb. 1824), Hitzig (geb. 1838), Meynert (geb. 1833) oder Westphal (geb. 1833) waren keine episodischen Erscheinungen, sondern die Führer einer Phalanx, zu der auch die zwei letzten Gudden-Schüler Forel (geb. 1848) und Kraepelin (geb. 1856) sowie die Schüler des ersteren E.Bleuler (geb.